查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654308

全球單位劑量製造市場：市場規模、佔有率、趨勢分析（按採購方式、產品、最終用途和地區）、細分市場預測（2025-2030 年）

Unit Dose Manufacturing Market Size, Share Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid, Solid), By End-use (Independent Pharmacies, Long Term Care), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

單位劑量製造市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球單位劑量製造市場規模預計到2030年將達到1506.1億美元，2025年至2030年期間的複合年成長率為11.43%。

2020 年上半年市場成長停滯，但在 2020 年代年終開始復甦。這主要是因為使用單位劑量治療 COVID-19，減少了處理和從同一瓶中倒出劑量所涉及的風險。

單位劑量配方有很多優點，包括易於識別藥物和在給藥前保護藥物配方。如果容器完好且藥物未使用，則可以重新處理和收集，而無需更改配方。最重要的優點是它允許管理正確的量並確保患者不超過規定的限度。

然而，COVID-19 疫情對醫藥市場產生了重大影響。在新冠疫情大流行的上半年，成長放緩，但到 2020年終市場開始復甦。在當前情況下，單位劑量製造具有優勢，因為它可以降低處理和污染風險。單位劑量疫苗也在醫院中廣泛用於治療 COVID-19 患者，以保護患者和醫護人員，因為它們消除了病毒透過空氣或直接接觸傳播的可能性。

單位劑量製造市場報告重點

  • 根據採購方式，外包部門在 2024 年佔據最大的收益市場佔有率，為 60.74%，佔據市場主導地位。由於成本效益、專業性、靈活性、風險緩解和全球市場准入等原因，外包服務在單位劑量製造業中佔據了主導地位。
  • 固態單位劑量部分在 2024 年佔據市場最大收入佔有率，達 50.49%。錠劑和膠囊等固態單位劑量形式由於其需求量大、應用範圍廣和患者方便而佔據單位劑量市場主導地位。
  • 根據最終用途，獨立藥局部門將在 2024 年以 39.11% 的最大收益佔有率引領市場，並且預計在預測期內將以最快的複合年成長率成長。
  • 2024 年，北美佔據單位劑量製造市場的主導地位，收益佔有率最大，為 37.73%。該地區先進的醫療保健基礎設施、高發病率的慢性病以及注重患者安全和用藥準確性的嚴格法規正在推動市場收益的成長。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 單位劑量製造市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 技術格局
  • 定價模式分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章單位劑量製造市場：按採購方法的估計和趨勢分析

  • 細分儀表板
  • 單位劑量製造市場：以採購方式進行的變化分析
  • 依來源分類（2018-2030 年）
  • 內部
  • 外包

第 5 章單位劑量製造市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 單位劑量製造市場：按產品進行的變化分析
  • 按產品（2018 - 2030 年）
  • 液體單位劑量
  • 固態單位劑量
  • 其他

6. 單位劑量製造市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • 單位劑量製造市場：最終用途變化分析
  • 依最終用途分類（2018-2030 年）
  • 獨立藥房
  • 長期照護機構
  • 醫院
  • 其他

第 7 章單位劑量製造市場：區域估計與趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 北美洲
    • 市場估計和預測，
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 市場估計和預測，
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 市場估計和預測，
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 市場估計和預測，
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 市場估計和預測，
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司分類
    • 市場領導
    • 新興企業
  • 2024 年企業市場分析（企業熱圖分析）
  • 公司簡介
    • Catalent Inc.
    • Unither Pharmaceuticals
    • Thermo Fisher Scientific
    • Corden Pharma
    • Mikart
    • Tape Mark
    • Renaissance Lakewood LLC
    • Medical Packaging Inc
    • American Health Packaging
    • PCI Pharma Services
    • Amcor PLC
    • Bristol-Myers Squibb
    • AbbVie Inc.
    • Merck &Co. Inc.
    • Pfizer Inc.
Product Code: GVR-4-68039-695-9

Unit Dose Manufacturing Market Growth & Trends:

The global unit dose manufacturing market size is expected to reach USD 150.61 billion by 2030, registering a CAGR of 11.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. In the first half of 2020, the growth of the market was stagnant, but the market started to recover by the end of 2020. It was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved while handling and pouring doses from the same bottle.

Unit dose manufacturing has many advantages as the drug can be easily identified, and the formulation of the drug is protected until the moment of administration. If the container is intact and the drug has not been used, it can be redisposed and retrieved without changing its formulation. The most important benefit is that it can be administered in the proper dosage and ensures that the patient does not exceed the prescribed limit.

However, the COVID-19 pandemic has a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth but by the end of 2020, the market started to recover. The unit dose manufacturing is lucratively used in the current scenario as it reduces the risk of handling and contamination. Also, unit doses are widely used in hospitals for COVID-19 patients to safeguard both patients and healthcare personnel to eliminate the possibility of viral transmission by airborne transmission or direct touch.

Unit Dose Manufacturing Market Report Highlights:

  • By sourcing, the outsourcing segment led the market with the largest revenue market share of 60.74% in 2024. Outsourcing services dominated the unit dose manufacturing industry, owing to cost-effectiveness, expertise, flexibility, risk reduction, and access to global markets.
  • The solid unit dose segment led the market with the largest revenue share of 50.49% in 2024. Solid unit dosage forms such as tablets and capsules dominate unit dose marketing due to their high demand, widespread applications, and patient convenience.
  • Based on end use, the independent pharmacies segment led the market with the largest revenue share of 39.11% in 2024 and is also anticipated to register at the fastest CAGR over the forecast period.
  • North America dominated the unit dose manufacturing market with the largest revenue share of 37.73% in 2024. The market revenue growth is driven by the region's advanced healthcare infrastructure, high prevalence of chronic diseases, and strong regulatory focus on patient safety and medication accuracy.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Unit Dose Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increased Adoption of Unit Doses
      • 3.2.1.2. Benefits of Manufacturing Unit Doses Over Repackaging
      • 3.2.1.3. Growing Outsourcing Activities
      • 3.2.1.4. Technological Advancements in Unit Dose Manufacturing
      • 3.2.1.5. Increasing Prevalence of Chronic Diseases and Demand for Personalized Medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges Associated with the Adoption of Manufactured Unit Doses
      • 3.2.2.2. Compliance Issues with Outsourcing
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Unit Dose Manufacturing Market: Sourcing Movement Analysis
  • 4.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Sourcing, 2018 - 2030 (USD Million)
  • 4.4. In-House
    • 4.4.1. In-House Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Outsourcing
    • 4.5.1. Outsourcing Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Unit Dose Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Unit Dose Manufacturing Market: Product Movement Analysis
  • 5.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
  • 5.4. Liquid Unit Dose
    • 5.4.1. Liquid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Solid Unit Dose
    • 5.5.1. Solid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Unit Dose Manufacturing Market: End Use Movement Analysis
  • 6.3. Unit Dose Manufacturing Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Independent Pharmacies
    • 6.4.1. Independent Pharmacies Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Long Term Care Facility
    • 6.5.1. Long Term Care Facility Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Unit Dose Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Catalent Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Unither Pharmaceuticals
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Thermo Fisher Scientific
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Corden Pharma
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Mikart
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Tape Mark
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Renaissance Lakewood LLC
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Medical Packaging Inc
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. American Health Packaging
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. PCI Pharma Services
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Amcor PLC
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Bristol-Myers Squibb
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. AbbVie Inc.
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Merck & Co. Inc.
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Service Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Pfizer Inc.
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Service Benchmarking
      • 8.3.15.4. Strategic Initiatives

List of Tables

  • Table. 1 Market segmentation
  • Table. 2 Market research process
  • Table. 3 Information procurement
  • Table. 4 Primary research pattern
  • Table. 5 Market research approaches
  • Table. 6 Value chain-based sizing & forecasting
  • Table. 7 QFD modelling for market share assessment
  • Table. 8 Market formulation & validation
  • Table. 9 Unit dose manufacturing market revenue, 2018 - 2030 (USD Million)
  • Table. 10 Unit dose manufacturing market snapshot
  • Table. 11 Unit dose manufacturing market driver impact
  • Table. 12 Unit dose manufacturing market restraint impact
  • Table. 13 Unit dose manufacturing sourcing key takeaways (USD Million)
  • Table. 14 Unit dose manufacturing market: Sourcing movement analysis
  • Table. 15 In-house market, 2018 - 2030 (USD Million)
  • Table. 16 Outsourcing market, 2018 - 2030 (USD Million)
  • Table. 17 Unit dose manufacturing market product key takeaways (USD Million)
  • Table. 18 Unit dose manufacturing market: Product movement analysis
  • Table. 19 Liquid unit dose market, 2018 - 2030 (USD Million)
  • Table. 20 Solid unit dose market, 2018 - 2030 (USD Million)
  • Table. 21 Others market, 2018 - 2030 (USD Million)
  • Table. 22 Unit dose manufacturing market end use key takeaways (USD Million)
  • Table. 23 Unit dose manufacturing market: End use movement analysis
  • Table. 24 Independent pharmacies market, 2018 - 2030 (USD Million)
  • Table. 25 Long term care facility market, 2018 - 2030 (USD Million)
  • Table. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Table. 27 Others market, 2018 - 2030 (USD Million)
  • Table. 28 Regional marketplace: Key takeaways
  • Table. 29 Regional outlook, 2024 & 2030
  • Table. 30 North America unit dose manufacturing Market, 2018 - 2030 (USD Million)
  • Table. 31 U.S. unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 32 Canada unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 33 Mexico unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 34 Europe unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 35 UK unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 36 Germany unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 37 France unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 38 Italy unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 39 Spain unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 40 Sweden unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 41 Denmark unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 42 Norway unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 43 Asia Pacific unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 44 Japan unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 45 China unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 46 India unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 47 Thailand unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 48 South Korea unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 49 Australia unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 50 Latin America unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 51 Brazil unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 52 Argentina unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 53 Middle East & Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 54 South Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 55 Saudi Arabia unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 56 UAE unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 57 Kuwait unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 58 Market participant categorization

List of Figures

  • Fig. 1 List of Tables
  • Fig. 2 List of Secondary Sources
  • Fig. 3 List of Abbreviations
  • Fig. 4 Global Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 5 Global Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 6 Global Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 7 Global Unit Dose Manufacturing, by Region, 2018 - 2030 (USD Million)
  • Fig. 8 North America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 9 North America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 10 North America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 11 North America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 12 U.S. Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 13 U.S. Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 15 Canada Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 16 Canada Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 17 Canada Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 18 Mexico Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 19 Mexico Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 20 Mexico Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 21 Europe Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 22 Europe Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 23 Europe Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 24 Europe Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 25 Germany Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 26 Germany Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 27 Germany Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 28 UK Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 29 UK Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 30 UK Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 31 France Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 32 France Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 33 France Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 34 Italy Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 53 China Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 54 China Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 55 China Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 58 Japan Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 59 India Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 60 India Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 61 India Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 65 Australia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 66 Australia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 67 Australia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 81 Middle East & Africa Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East & Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East & Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 85 South Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 91 UAE Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 93 UAE Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)